Moolec Science SA (NASDAQ:MLEC) Short Interest Update

Posted by Dante Gardener on Sep 1st, 2026

Moolec Science SA (NASDAQ:MLEC – Get Free Report) was the target of a significant drop in short interest during the month of August. As of August 14th, there was short interest totaling 2,933 shares, a drop of 35.0% from the July 30th total of 4,512 shares. Based on an average trading volume of 2,784 shares, the short-interest ratio is currently 1.1 days. Approximately 0.5% of the company’s shares are short sold.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen raised Moolec Science from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th.

Check Out Our Latest Analysis on Moolec Science

Moolec Science Stock Up 1.5%

NASDAQ:MLEC traded up $0.10 during trading hours on Tuesday, hitting $6.90. The company’s stock had a trading volume of 11,808 shares, compared to its average volume of 603,419. The company has a current ratio of 0.15, a quick ratio of 0.08 and a debt-to-equity ratio of 0.79. Moolec Science has a 52-week low of $3.08 and a 52-week high of $23.22. The stock has a market capitalization of $5.04 million, a P/E ratio of -0.21 and a beta of 0.26. The stock has a fifty day moving average of $7.27 and a 200-day moving average of $8.26.

Institutional Inflows and Outflows

An institutional investor recently bought a new stake in Moolec Science stock. Citadel Advisors LLC bought a new stake in Moolec Science SA (NASDAQ:MLEC – Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned 0.90% of Moolec Science at the end of the most recent reporting period. Hedge funds and other institutional investors own 0.07% of the company’s stock.

About Moolec Science

(Get Free Report)

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.